Transgenic mice expressing HCCR developed metastatic breast cancer, and the levels of p21WAF1, MDM2, and bax decreased in the spontaneous breast cancer cells and metastatic tumours of HCCR transgenic mice6. The gene discussed is MDM2; the disease is breast cancer.